Biomarkers

Biomarkers are a naturally occurring molecule, gene, or characteristic by which a particular disease can be identified.

news

Pharma R&D Europe summits series – registration closing

16 May 2014 | By Oxford Global Conferences

Registration is now closing for Oxford Global’s Pharma R&D Europe Series, the leading pharmaceutical discussion forum in Europe...

article

Drug Target Review – Issue #1 2014

9 May 2014 | By Guido Rasi, Professor Sir Mark Pepys, Kenji Schorpp et al.

We are delighted to welcome you to the inaugural issue of European Drug Target Review, a magazine focused on the changing landscape of the drug discovery industry...

article

Academia Big Pharma collaboration in drug development

5 May 2014 | By Professor Sir Mark Pepys FRS FMedSci (University College London)

Clearly what is needed is a synergistic collaboration bringing together the respective competence and expertise of academia and industry. All the major pharmaceutical companies have recognised this need and have introduced a range of different models for association with academia and small biotech or biopharma companies. Attempted solutions range from…

article

Oncology biomarkers in clinical practice – a new horizon

4 May 2014 | By Heidi Olzscha (University of Oxford), Nicholas B. La Thangue (University of Oxford), Semira Sheikh (University of Oxford)

The ability to individualise a patient’s care has become a particularly pressing issue in the field of cancer therapeutics as there is a growing recognition that both the global incidence of cancer is steadily rising and the associated costs in terms of treatment and lost productivity are ever increasing. Advances…